| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB6D ATP5PB DHX36 ATP8B4 ERCC3 ABCA4 ATP7A LRRK2 RAB6B ARL5A RAB6C RAB41 DHX9 EEF2 ARL5B KIF15 SLFN13 ATP2C2 SMARCA4 HFM1 ABCC2 RAB6A RAB5C RHOT1 | 1.09e-07 | 775 | 178 | 24 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB6D ATP5PB DHX36 ATP8B4 ERCC3 ABCA4 ATP7A LRRK2 RAB6B ARL5A RAB6C RAB41 DHX9 EEF2 ARL5B KIF15 SLFN13 ATP2C2 SMARCA4 HFM1 ABCC2 RAB6A RAB5C RHOT1 | 4.63e-07 | 839 | 178 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB6D ATP5PB DHX36 ATP8B4 ERCC3 ABCA4 ATP7A LRRK2 RAB6B ARL5A RAB6C RAB41 DHX9 EEF2 ARL5B KIF15 SLFN13 ATP2C2 SMARCA4 HFM1 ABCC2 RAB6A RAB5C RHOT1 | 4.73e-07 | 840 | 178 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB6D ATP5PB DHX36 ATP8B4 ERCC3 ABCA4 ATP7A LRRK2 RAB6B ARL5A RAB6C RAB41 DHX9 EEF2 ARL5B KIF15 SLFN13 ATP2C2 SMARCA4 HFM1 ABCC2 RAB6A RAB5C RHOT1 | 4.73e-07 | 840 | 178 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 9.64e-07 | 21 | 178 | 5 | GO:0061676 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.17e-05 | 100 | 178 | 7 | GO:0030594 | |
| GeneOntologyMolecularFunction | GTPase activity | RAB6D ABCA4 LRRK2 RAB6B ARL5A RAB6C RAB41 EEF2 ARL5B RAB6A RAB5C RHOT1 | 5.82e-05 | 341 | 178 | 12 | GO:0003924 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP5PB DHX36 ATP8B4 ERCC3 ABCA4 ATP7A DHX9 KIF15 SLFN13 ATP2C2 SMARCA4 HFM1 ABCC2 | 1.70e-04 | 441 | 178 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | transporter activity | ATP5PB ATP8B4 ABCA4 ATP7A CETP PKD1L1 GRIA1 ATG2A SLC47A2 SLC3A1 RYR3 SLC12A5 SLCO5A1 SLC25A36 SIDT2 SLC16A4 NALCN ATP2C2 MTTP KCNQ1 SLC13A5 SLC25A29 ABCC2 GABRA2 GABRA4 | 2.00e-04 | 1289 | 178 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 2.36e-04 | 3 | 178 | 2 | GO:0001591 | |
| GeneOntologyMolecularFunction | GTP binding | RAB6D LRRK2 RAB6B ARL5A RAB6C RAB41 EEF2 ARL5B GUCY2F RAB6A RAB5C RHOT1 | 2.42e-04 | 397 | 178 | 12 | GO:0005525 |
| GeneOntologyMolecularFunction | microtubule binding | MAP7D3 KIF26B LRRK2 GOLGA6C GOLGA6D GOLGA6B GOLGA6A REEP3 SPC24 KIF15 | 4.59e-04 | 308 | 178 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.55e-04 | 75 | 178 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | RAB6D LRRK2 RAB6B ARL5A RAB6C RAB41 EEF2 ARL5B GUCY2F RAB6A RAB5C RHOT1 | 5.95e-04 | 439 | 178 | 12 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | RAB6D LRRK2 RAB6B ARL5A RAB6C RAB41 EEF2 ARL5B GUCY2F RAB6A RAB5C RHOT1 | 5.95e-04 | 439 | 178 | 12 | GO:0019001 |
| GeneOntologyMolecularFunction | myosin V binding | 7.10e-04 | 20 | 178 | 3 | GO:0031489 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 7.76e-04 | 5 | 178 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | syntaxin binding | 1.09e-03 | 87 | 178 | 5 | GO:0019905 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5PB DHX36 ATP8B4 ERCC3 ABCA4 ATP7A KIF26B DHX9 KIF15 SLFN13 ATP2C2 SMARCA4 HFM1 ABCC2 | 1.25e-03 | 614 | 178 | 14 | GO:0140657 |
| GeneOntologyBiologicalProcess | protein localization to Golgi membrane | 2.54e-08 | 5 | 176 | 4 | GO:1903292 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | SDK2 DSC2 PCDHGA11 PCDHGA4 CDH23 CDHR5 PCDHA2 PCDH12 FAT1 PTPRF PCDH15 SDK1 | 7.47e-08 | 187 | 176 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | SDK2 DSC2 PCDHGA11 PCDHGA4 CDH23 CDHR5 PCDHA2 PCDH12 TENM2 FAT1 PTPRF PCDH15 TENM1 CLDN5 SDK1 | 8.27e-08 | 313 | 176 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SDK2 DSC2 PCDHGA11 KIF26B PCDHGA4 PKD1L1 ITGA6 CDH23 PELI1 CDHR5 PCDHA2 PCDH12 ITGAD ITGAX SLAMF1 TENM2 FAT1 PTPRF PIK3CA PCDH15 PKHD1 TENM1 SMARCA4 CLDN5 IL2RA SDK1 ALOX5 | 4.68e-07 | 1077 | 176 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | organelle inheritance | 3.58e-06 | 28 | 176 | 5 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 3.58e-06 | 28 | 176 | 5 | GO:0048313 | |
| GeneOntologyBiologicalProcess | neuron development | SLC25A46 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D ITGA6 CDH23 GOLGA6B GOLGA6A PLXND1 PCDH12 RAB6B TENM2 SLC12A5 PTPRF PCDH15 TENM1 SYN1 PAK3 KCNQ1 PBX2 ULK2 SDK1 RAB6A VPS13B | 6.36e-06 | 1463 | 176 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | protein localization to Golgi apparatus | 7.14e-06 | 32 | 176 | 5 | GO:0034067 | |
| GeneOntologyBiologicalProcess | intra-Golgi vesicle-mediated transport | 1.13e-05 | 35 | 176 | 5 | GO:0006891 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 1.43e-05 | 18 | 176 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | Golgi organization | ATP8B4 LRRK2 GOLGA6C GOLGA6D GOLGA6B GOLGA6A TRAPPC8 RAB6B VPS13B | 1.44e-05 | 168 | 176 | 9 | GO:0007030 |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 1.80e-05 | 19 | 176 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SLC25A46 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D CDH23 GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PCDH15 PAK3 ULK2 | 2.27e-05 | 748 | 176 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | VIL1 DHX36 ATP7A KALRN GOLGA6C GOLGA6D ITGA6 GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PIK3CA TENM1 PAK3 | 2.32e-05 | 494 | 176 | 15 | GO:0031346 |
| GeneOntologyBiologicalProcess | synapse organization | SLC25A46 DHX36 SDK2 DRD2 HTR1A KALRN LRRK2 ADGRB1 GRIA1 CNKSR2 PLXND1 PTPRF SYN1 CHRD PAK3 SDK1 GABRA2 GABRA4 | 2.42e-05 | 685 | 176 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SLC25A46 VIL1 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D CDH23 GOLGA6B GOLGA6A PLXND1 TENM2 FAT1 SIDT2 PTPRF PTPRJ PCDH15 PKHD1 SMARCA4 PAK3 ULK2 | 2.94e-05 | 1194 | 176 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell junction organization | SLC25A46 DHX36 SDK2 DRD2 HTR1A KALRN LRRK2 ADGRB1 ITGA6 GRIA1 CNKSR2 PLXND1 PTPRF PTPRJ PKHD1 SYN1 CHRD PAK3 CLDN5 SDK1 GABRA2 GABRA4 | 3.02e-05 | 974 | 176 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | RAB6D LRRK2 GOLGA6C GOLGA6D GOLGA6B GOLGA6A TRAPPC8 RAB6B RAB6C RAB41 RAB6A TRAPPC6A | 3.62e-05 | 339 | 176 | 12 | GO:0048193 |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 4.00e-05 | 23 | 176 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 4.76e-05 | 24 | 176 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 5.09e-05 | 77 | 176 | 6 | GO:0051289 | |
| GeneOntologyBiologicalProcess | Golgi localization | 7.71e-05 | 27 | 176 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 8.80e-05 | 53 | 176 | 5 | GO:0006890 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 8.94e-05 | 28 | 176 | 4 | GO:0090306 | |
| GeneOntologyBiologicalProcess | regulation of dopamine receptor signaling pathway | 9.58e-05 | 11 | 176 | 3 | GO:0060159 | |
| GeneOntologyBiologicalProcess | neuron projection development | SLC25A46 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D ITGA6 CDH23 GOLGA6B GOLGA6A PLXND1 RAB6B TENM2 SLC12A5 PTPRF PCDH15 PAK3 ULK2 SDK1 RAB6A VPS13B | 9.64e-05 | 1285 | 176 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | VIL1 DHX36 ATP7A KALRN LRRK2 GOLGA6C GOLGA6D ITGA6 CDHR5 GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PIK3CA TENM1 PAK3 MPHOSPH9 ULK2 | 1.17e-04 | 846 | 176 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | VIL1 DHX36 ATP7A KALRN LRRK2 GOLGA6C GOLGA6D ITGA6 CDHR5 GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PIK3CA TENM1 PAK3 MPHOSPH9 ULK2 | 1.51e-04 | 863 | 176 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | asymmetric cell division | 1.95e-04 | 34 | 176 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SLC25A46 VIL1 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PAK3 ULK2 | 2.32e-04 | 819 | 176 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | DHX36 DRD2 SPINT1 KALRN GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 PTPRF PAK3 | 2.40e-04 | 354 | 176 | 11 | GO:0050769 |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 2.44e-04 | 36 | 176 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SLC25A46 VIL1 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PAK3 ULK2 | 2.58e-04 | 826 | 176 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | DHX36 DRD2 SPINT1 KALRN ADGRB1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 PTPRF PAK3 | 2.60e-04 | 418 | 176 | 12 | GO:0051962 |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | DHX36 LAPTM4B LRRK2 ADGRB1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A USP19 DHX9 IGF2BP2 PIK3CA | 2.60e-04 | 418 | 176 | 12 | GO:0009895 |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 2.72e-04 | 37 | 176 | 4 | GO:0000212 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 2.99e-04 | 106 | 176 | 6 | GO:0032091 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | DHX36 DRD2 DRD3 SPINT1 KALRN ADGRB1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 ITGAX PTPRF PAK3 ULK2 | 3.14e-04 | 625 | 176 | 15 | GO:0051960 |
| GeneOntologyBiologicalProcess | intracellular chloride ion homeostasis | 3.15e-04 | 16 | 176 | 3 | GO:0030644 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | GOLGA6C GOLGA6D GOLGA6B GOLGA6A SPC24 KIF15 SMARCA4 CDC27 KNL1 | 3.44e-04 | 254 | 176 | 9 | GO:0000819 |
| GeneOntologyBiologicalProcess | retrograde transport, endosome to Golgi | 3.47e-04 | 109 | 176 | 6 | GO:0042147 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 3.68e-04 | 40 | 176 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 3.76e-04 | 204 | 176 | 8 | GO:1903008 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic anion homeostasis | 3.80e-04 | 17 | 176 | 3 | GO:0030002 | |
| GeneOntologyBiologicalProcess | locomotion involved in locomotory behavior | 3.80e-04 | 17 | 176 | 3 | GO:0031987 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translation | 3.80e-04 | 17 | 176 | 3 | GO:2000767 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 4.02e-04 | 112 | 176 | 6 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 4.21e-04 | 113 | 176 | 6 | GO:0051262 | |
| GeneOntologyBiologicalProcess | social behavior | 4.28e-04 | 74 | 176 | 5 | GO:0035176 | |
| GeneOntologyBiologicalProcess | negative regulation of dopamine receptor signaling pathway | 4.30e-04 | 4 | 176 | 2 | GO:0060160 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 4.39e-04 | 159 | 176 | 7 | GO:0006888 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 4.84e-04 | 76 | 176 | 5 | GO:0051703 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | DHX36 DRD2 DRD3 SPINT1 KALRN GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 PTPRF PAK3 ULK2 | 4.95e-04 | 515 | 176 | 13 | GO:0050767 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SLC25A46 DHX36 DRD2 ATP7A ARHGEF28 KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 TENM2 PTPRF PAK3 ULK2 | 5.26e-04 | 802 | 176 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | centrosome cycle | 5.29e-04 | 164 | 176 | 7 | GO:0007098 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | VIL1 DHX36 DRD2 DRD3 HTR1A ATP7A KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D ITGA6 GOLGA6B GOLGA6A PLXND1 ATG2A TENM2 VPS13D PTPRF PTPRJ PIK3CA TENM1 PAK3 CLDN5 | 5.99e-04 | 1366 | 176 | 24 | GO:0051130 |
| GeneOntologyBiologicalProcess | behavior | SLC25A46 DRD2 DRD3 HTR1A ATP7A KALRN LRRK2 CDH23 GRIA1 SLC12A5 PTCHD1 CFAP20 PCDH15 CHRD KCNQ1 CLDN5 SDK1 VPS13B | 6.32e-04 | 891 | 176 | 18 | GO:0007610 |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 6.33e-04 | 122 | 176 | 6 | GO:0045132 | |
| GeneOntologyBiologicalProcess | positive regulation of dopamine receptor signaling pathway | 7.12e-04 | 5 | 176 | 2 | GO:0060161 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 7.82e-04 | 228 | 176 | 8 | GO:0043393 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | DHX36 DRD2 SPINT1 KALRN GOLGA6C GOLGA6D GOLGA6B GOLGA6A PLXND1 PTPRF SMARCA4 PAK3 CLDN5 IL2RA | 8.21e-04 | 614 | 176 | 14 | GO:0010720 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 8.87e-04 | 179 | 176 | 7 | GO:0031023 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | MGAT4B ATP8B4 ATP7A LRRK2 GOLGA6C GOLGA6D GOLGA6B GOLGA6A BIRC6 ARL5A ARL5B ATP2C2 RAB6A VPS13B TRAPPC6A | 6.74e-06 | 443 | 179 | 15 | GO:0098791 |
| GeneOntologyCellularComponent | actin-based cell projection | VIL1 ATP7A LRRK2 ITGA6 CDH23 CDHR5 PKHD1L1 TENM2 FAT1 PCDH15 MTTP | 2.91e-05 | 278 | 179 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | cis-Golgi network | 9.05e-05 | 85 | 179 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | cell projection membrane | DRD2 ATP7A PKD1L1 GRIA1 CDHR5 PLXND1 SLC3A1 SLC12A5 PTPRJ MTTP ABCC2 GABRA2 GABRA4 | 9.16e-05 | 431 | 179 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | postsynaptic specialization | DRD3 ATP7A GPR50 KALRN ADGRB1 GRIA1 CNKSR2 SLC12A5 PTPRF SYN1 SYN2 PAK3 GABRA2 GABRA4 | 1.15e-04 | 503 | 179 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.35e-04 | 223 | 179 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 1.75e-04 | 33 | 179 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | trans-Golgi network | ATP8B4 ATP7A LRRK2 BIRC6 ARL5A ARL5B ATP2C2 RAB6A VPS13B TRAPPC6A | 3.19e-04 | 306 | 179 | 10 | GO:0005802 |
| GeneOntologyCellularComponent | brush border membrane | 7.37e-04 | 83 | 179 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DHX36 DRD2 HTR1A ATP7A HTR1E KALRN LRRK2 ADGRB1 GOLGA6C GOLGA6D GRIA1 GOLGA6B CNKSR2 GOLGA6A TENM2 SLC12A5 PTPRF SYN1 KCNQ1 ALOX5 GABRA2 GABRA4 | 8.40e-04 | 1228 | 179 | 22 | GO:0036477 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 9.06e-04 | 179 | 179 | 7 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 9.06e-04 | 179 | 179 | 7 | GO:0030672 | |
| GeneOntologyCellularComponent | cell body | DHX36 DRD2 HTR1A ATP7A KALRN LRRK2 GOLGA6C GOLGA6D GRIA1 GOLGA6B CNKSR2 GOLGA6A PLXND1 SLC12A5 PTPRF SYN1 KCNQ1 GABRA2 | 1.07e-03 | 929 | 179 | 18 | GO:0044297 |
| GeneOntologyCellularComponent | multivesicular body, internal vesicle | 1.07e-03 | 6 | 179 | 2 | GO:0097487 | |
| GeneOntologyCellularComponent | dendrite membrane | 1.35e-03 | 56 | 179 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | non-motile cilium | 1.53e-03 | 196 | 179 | 7 | GO:0097730 | |
| GeneOntologyCellularComponent | receptor complex | IL13RA2 DRD2 ITGA6 GRIA1 PLXND1 ITGAD ITGAX IFNLR1 MTTP IL2RA NBR1 GABRA2 GABRA4 | 1.54e-03 | 581 | 179 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.64e-03 | 59 | 179 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.77e-03 | 201 | 179 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic density | DRD3 ATP7A GPR50 KALRN ADGRB1 GRIA1 CNKSR2 PTPRF SYN1 SYN2 PAK3 | 1.81e-03 | 451 | 179 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | perichromatin fibrils | 1.97e-03 | 8 | 179 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | brush border | 2.00e-03 | 152 | 179 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | neuronal cell body | DHX36 DRD2 HTR1A ATP7A KALRN LRRK2 GOLGA6C GOLGA6D GRIA1 GOLGA6B CNKSR2 GOLGA6A SLC12A5 PTPRF KCNQ1 GABRA2 | 2.26e-03 | 835 | 179 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | integrin complex | 2.55e-03 | 32 | 179 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.58e-03 | 110 | 179 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | postsynaptic membrane | DRD2 DRD3 ADGRB1 GRIA1 CNKSR2 TENM2 SLC12A5 PTPRF GABRA2 GABRA4 | 2.65e-03 | 405 | 179 | 10 | GO:0045211 |
| MousePheno | abnormal Golgi vesicle transport | 7.31e-08 | 22 | 145 | 6 | MP:0030949 | |
| MousePheno | abnormal actin cytoskeleton morphology | 1.19e-06 | 34 | 145 | 6 | MP:0020849 | |
| MousePheno | increased alveolar macrophage number | 1.03e-05 | 14 | 145 | 4 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 1.39e-05 | 15 | 145 | 4 | MP:0014227 | |
| MousePheno | liver fibrosis | 1.47e-05 | 77 | 145 | 7 | MP:0003333 | |
| MousePheno | absent acrosome | 1.80e-05 | 32 | 145 | 5 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 2.10e-05 | 33 | 145 | 5 | MP:0011743 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 1.00e-04 | 24 | 145 | 4 | MP:0031355 | |
| MousePheno | abnormal cell cytoskeleton morphology | 1.26e-04 | 75 | 145 | 6 | MP:0020378 | |
| MousePheno | decreased body length | DRD2 DUSP8 PHRF1 GOLGA6C GOLGA6D CDH23 PELI1 GOLGA6B GOLGA6A RAB6B IGF2BP2 PIK3CA SLC13A5 IL2RA VPS13B | 1.52e-04 | 484 | 145 | 15 | MP:0001258 |
| MousePheno | abnormal alveolar macrophage morphology | 1.62e-04 | 27 | 145 | 4 | MP:0008245 | |
| MousePheno | cochlear ganglion hypoplasia | 1.70e-04 | 11 | 145 | 3 | MP:0003637 | |
| MousePheno | absent sperm mitochondrial sheath | 1.87e-04 | 28 | 145 | 4 | MP:0009833 | |
| Domain | Cadherin_CS | 8.25e-07 | 109 | 174 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 1.12e-06 | 113 | 174 | 9 | PS00232 | |
| Domain | CADHERIN_2 | 1.20e-06 | 114 | 174 | 9 | PS50268 | |
| Domain | - | 1.20e-06 | 114 | 174 | 9 | 2.60.40.60 | |
| Domain | CA | 1.30e-06 | 115 | 174 | 9 | SM00112 | |
| Domain | Cadherin-like | 1.39e-06 | 116 | 174 | 9 | IPR015919 | |
| Domain | Cadherin | 1.61e-06 | 118 | 174 | 9 | IPR002126 | |
| Domain | Small_GTP-bd_dom | 3.81e-06 | 167 | 174 | 10 | IPR005225 | |
| Domain | Cadherin | 1.08e-05 | 113 | 174 | 8 | PF00028 | |
| Domain | Small_GTPase | 1.94e-05 | 160 | 174 | 9 | IPR001806 | |
| Domain | GOLGA2L5 | 2.01e-05 | 18 | 174 | 4 | PF15070 | |
| Domain | Golgin_A | 2.01e-05 | 18 | 174 | 4 | IPR024858 | |
| Domain | Chorein_N | 4.30e-05 | 8 | 174 | 3 | PF12624 | |
| Domain | VPS13_N | 4.30e-05 | 8 | 174 | 3 | IPR026854 | |
| Domain | FN3 | 1.06e-04 | 199 | 174 | 9 | PS50853 | |
| Domain | P-loop_NTPase | DHX36 ERCC3 ABCA4 KIF26B LRRK2 RAB6B ARL5A RAB6C RAB41 DHX9 EEF2 ARL5B KIF15 SLFN13 SMARCA4 HFM1 ABCC2 RAB6A RAB5C RHOT1 | 1.28e-04 | 848 | 174 | 20 | IPR027417 |
| Domain | FN3_dom | 1.54e-04 | 209 | 174 | 9 | IPR003961 | |
| Domain | - | 2.12e-04 | 13 | 174 | 3 | 3.40.50.20 | |
| Domain | - | DHX36 ERCC3 ABCA4 LRRK2 RAB6B ARL5A RAB6C RAB41 DHX9 EEF2 ARL5B SLFN13 SMARCA4 HFM1 ABCC2 RAB6A RAB5C RHOT1 | 2.15e-04 | 746 | 174 | 18 | 3.40.50.300 |
| Domain | Synapsin_pre-ATP-grasp_dom | 2.57e-04 | 3 | 174 | 2 | IPR020897 | |
| Domain | Synapsin_ATP-bd_dom | 2.57e-04 | 3 | 174 | 2 | IPR020898 | |
| Domain | SYNAPSIN_1 | 2.57e-04 | 3 | 174 | 2 | PS00415 | |
| Domain | SYNAPSIN_2 | 2.57e-04 | 3 | 174 | 2 | PS00416 | |
| Domain | Synapsin_C | 2.57e-04 | 3 | 174 | 2 | PF02750 | |
| Domain | Synapsin_N | 2.57e-04 | 3 | 174 | 2 | PF10581 | |
| Domain | Synapsin_CS | 2.57e-04 | 3 | 174 | 2 | IPR019735 | |
| Domain | Synapsin_P_site | 2.57e-04 | 3 | 174 | 2 | IPR019736 | |
| Domain | Synapsin | 2.57e-04 | 3 | 174 | 2 | PF02078 | |
| Domain | Synapsin | 2.57e-04 | 3 | 174 | 2 | IPR001359 | |
| Domain | PreATP-grasp_dom | 2.68e-04 | 14 | 174 | 3 | IPR016185 | |
| Domain | - | 3.33e-04 | 15 | 174 | 3 | 3.30.1490.20 | |
| Domain | Integrin_alpha_C_CS | 4.07e-04 | 16 | 174 | 3 | IPR018184 | |
| Domain | Tox-GHH_dom | 5.11e-04 | 4 | 174 | 2 | IPR028916 | |
| Domain | SHR-BD | 5.11e-04 | 4 | 174 | 2 | IPR009543 | |
| Domain | G8_domain | 5.11e-04 | 4 | 174 | 2 | IPR019316 | |
| Domain | G8 | 5.11e-04 | 4 | 174 | 2 | PS51484 | |
| Domain | Tox-GHH | 5.11e-04 | 4 | 174 | 2 | PF15636 | |
| Domain | G8 | 5.11e-04 | 4 | 174 | 2 | SM01225 | |
| Domain | Ten_N | 5.11e-04 | 4 | 174 | 2 | IPR009471 | |
| Domain | Ten_N | 5.11e-04 | 4 | 174 | 2 | PF06484 | |
| Domain | G8 | 5.11e-04 | 4 | 174 | 2 | PF10162 | |
| Domain | VPS13_C | 5.11e-04 | 4 | 174 | 2 | PF16909 | |
| Domain | VPS13_C | 5.11e-04 | 4 | 174 | 2 | IPR031645 | |
| Domain | TENEURIN_N | 5.11e-04 | 4 | 174 | 2 | PS51361 | |
| Domain | SHR-BD | 5.11e-04 | 4 | 174 | 2 | PF06650 | |
| Domain | Integrin_alpha-2 | 5.85e-04 | 18 | 174 | 3 | IPR013649 | |
| Domain | ATP_grasp_subdomain_1 | 5.85e-04 | 18 | 174 | 3 | IPR013815 | |
| Domain | - | 5.85e-04 | 18 | 174 | 3 | 3.30.470.20 | |
| Domain | INTEGRIN_ALPHA | 5.85e-04 | 18 | 174 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 5.85e-04 | 18 | 174 | 3 | PF08441 | |
| Domain | Integrin_alpha | 5.85e-04 | 18 | 174 | 3 | IPR000413 | |
| Domain | RAB | 5.97e-04 | 73 | 174 | 5 | PS51419 | |
| Domain | Int_alpha | 6.90e-04 | 19 | 174 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 6.90e-04 | 19 | 174 | 3 | IPR013519 | |
| Domain | fn3 | 8.20e-04 | 162 | 174 | 7 | PF00041 | |
| Domain | NIDO_dom | 8.47e-04 | 5 | 174 | 2 | IPR003886 | |
| Domain | NIDO | 8.47e-04 | 5 | 174 | 2 | SM00539 | |
| Domain | NIDO | 8.47e-04 | 5 | 174 | 2 | PF06119 | |
| Domain | NIDO | 8.47e-04 | 5 | 174 | 2 | PS51220 | |
| Domain | YD | 8.47e-04 | 5 | 174 | 2 | IPR006530 | |
| Domain | Autophagy-rel_C | 8.47e-04 | 5 | 174 | 2 | IPR015412 | |
| Domain | ATG_C | 8.47e-04 | 5 | 174 | 2 | PF09333 | |
| Domain | Dopamine_rcpt | 8.47e-04 | 5 | 174 | 2 | IPR000929 | |
| Domain | FG_GAP | 1.07e-03 | 22 | 174 | 3 | PS51470 | |
| Domain | Quino_amine_DH_bsu | 1.07e-03 | 22 | 174 | 3 | IPR011044 | |
| Domain | PbH1 | 1.26e-03 | 6 | 174 | 2 | SM00710 | |
| Domain | PbH1 | 1.26e-03 | 6 | 174 | 2 | IPR006626 | |
| Domain | GABAAa_rcpt | 1.26e-03 | 6 | 174 | 2 | IPR001390 | |
| Domain | FG-GAP | 1.39e-03 | 24 | 174 | 3 | PF01839 | |
| Domain | FG-GAP | 1.39e-03 | 24 | 174 | 3 | IPR013517 | |
| Domain | Integrin_dom | 1.57e-03 | 25 | 174 | 3 | IPR032695 | |
| Domain | Ras | 1.74e-03 | 136 | 174 | 6 | PF00071 | |
| Domain | FN3 | 1.77e-03 | 185 | 174 | 7 | SM00060 | |
| Domain | VWA | 1.83e-03 | 56 | 174 | 4 | PF00092 | |
| Domain | IPT | 1.97e-03 | 27 | 174 | 3 | SM00429 | |
| Domain | Pectin_lyase_fold/virulence | 2.33e-03 | 8 | 174 | 2 | IPR011050 | |
| Domain | DH_1 | 2.83e-03 | 63 | 174 | 4 | PS00741 | |
| Domain | ATP_grasp_subdomain_2 | 2.95e-03 | 31 | 174 | 3 | IPR013816 | |
| Domain | TIG | 2.95e-03 | 31 | 174 | 3 | PF01833 | |
| Domain | 5HT_rcpt | 2.98e-03 | 9 | 174 | 2 | IPR002231 | |
| Domain | Cadherin_2 | 3.17e-03 | 65 | 174 | 4 | PF08266 | |
| Domain | Cadherin_N | 3.17e-03 | 65 | 174 | 4 | IPR013164 | |
| Domain | IPT | 3.23e-03 | 32 | 174 | 3 | IPR002909 | |
| Domain | Helicase_C | 3.28e-03 | 107 | 174 | 5 | PF00271 | |
| Domain | HELICc | 3.28e-03 | 107 | 174 | 5 | SM00490 | |
| Domain | Helicase_C | 3.41e-03 | 108 | 174 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 3.55e-03 | 109 | 174 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.55e-03 | 109 | 174 | 5 | PS51192 | |
| Domain | DEXDc | 3.55e-03 | 109 | 174 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.69e-03 | 110 | 174 | 5 | IPR014001 | |
| Domain | A2M | 3.70e-03 | 10 | 174 | 2 | PF00207 | |
| Domain | A2M_N_2 | 3.70e-03 | 10 | 174 | 2 | IPR011625 | |
| Domain | A2M_comp | 3.70e-03 | 10 | 174 | 2 | IPR011626 | |
| Domain | A2M_recep | 3.70e-03 | 10 | 174 | 2 | PF07677 | |
| Domain | A2M_comp | 3.70e-03 | 10 | 174 | 2 | PF07678 | |
| Domain | A2M_N | 3.70e-03 | 10 | 174 | 2 | PF01835 | |
| Domain | A2M_N | 3.70e-03 | 10 | 174 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 3.70e-03 | 10 | 174 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 3.70e-03 | 10 | 174 | 2 | PS00477 | |
| Domain | A2M_N_2 | 3.70e-03 | 10 | 174 | 2 | PF07703 | |
| Pathway | WP_FOXA2_PATHWAY | 4.00e-05 | 21 | 133 | 4 | M42579 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 5.83e-05 | 23 | 133 | 4 | MM14620 | |
| Pubmed | ATP7A ACACA MAP7D3 DSC2 DNAJC16 LRRK2 MUC16 CNKSR2 PLXND1 KBTBD2 BIRC6 PKHD1L1 ARL5A USP19 DHX9 EEF2 FAT1 ARL5B SLFN13 MPHOSPH9 SDK1 | 9.62e-10 | 777 | 182 | 21 | 35844135 | |
| Pubmed | 7.06e-08 | 21 | 182 | 5 | 15229288 | ||
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 25492866 | ||
| Pubmed | 1.81e-07 | 25 | 182 | 5 | 27471260 | ||
| Pubmed | PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. | 2.23e-07 | 26 | 182 | 5 | 32673396 | |
| Pubmed | Neuronal expression of ILEI/FAM3C and its reduction in Alzheimer's disease. | 2.73e-07 | 27 | 182 | 5 | 27256505 | |
| Pubmed | Beclin 1 regulates recycling endosome and is required for skin development in mice. | 2.73e-07 | 27 | 182 | 5 | 30701202 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 5.00e-07 | 13 | 182 | 4 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 5.00e-07 | 13 | 182 | 4 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 5.00e-07 | 13 | 182 | 4 | 32873390 | |
| Pubmed | 5.00e-07 | 13 | 182 | 4 | 21552007 | ||
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 5.00e-07 | 13 | 182 | 4 | 28028212 | |
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 5.00e-07 | 13 | 182 | 4 | 29128360 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 31847007 | ||
| Pubmed | 6.77e-07 | 59 | 182 | 6 | 26371508 | ||
| Pubmed | 6.97e-07 | 14 | 182 | 4 | 37831422 | ||
| Pubmed | 6.97e-07 | 14 | 182 | 4 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 6.97e-07 | 14 | 182 | 4 | 27226319 | |
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 6.97e-07 | 14 | 182 | 4 | 33543287 | |
| Pubmed | 8.58e-07 | 192 | 182 | 9 | 20602615 | ||
| Pubmed | Lis1 mediates planar polarity of auditory hair cells through regulation of microtubule organization. | 9.14e-07 | 34 | 182 | 5 | 23533177 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 9.47e-07 | 15 | 182 | 4 | 23185636 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 9.47e-07 | 15 | 182 | 4 | 17046993 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 9.47e-07 | 15 | 182 | 4 | 17189423 | |
| Pubmed | 9.47e-07 | 15 | 182 | 4 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 9.47e-07 | 15 | 182 | 4 | 28509431 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 9.47e-07 | 15 | 182 | 4 | 26165940 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 9.47e-07 | 15 | 182 | 4 | 17204322 | |
| Pubmed | 9.47e-07 | 15 | 182 | 4 | 16413118 | ||
| Pubmed | 9.47e-07 | 15 | 182 | 4 | 26083584 | ||
| Pubmed | 1.26e-06 | 16 | 182 | 4 | 16399995 | ||
| Pubmed | 1.26e-06 | 16 | 182 | 4 | 18166528 | ||
| Pubmed | 1.26e-06 | 16 | 182 | 4 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 1.26e-06 | 16 | 182 | 4 | 21640725 | |
| Pubmed | 1.26e-06 | 16 | 182 | 4 | 16336229 | ||
| Pubmed | 1.64e-06 | 17 | 182 | 4 | 28717168 | ||
| Pubmed | 1.64e-06 | 17 | 182 | 4 | 27655914 | ||
| Pubmed | 1.64e-06 | 17 | 182 | 4 | 14728599 | ||
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 1.64e-06 | 17 | 182 | 4 | 14718562 | |
| Pubmed | 1.64e-06 | 17 | 182 | 4 | 20004763 | ||
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 15800058 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 2.10e-06 | 18 | 182 | 4 | 20230794 | |
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 25208654 | ||
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 21147753 | ||
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 24227724 | ||
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 22718342 | ||
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 12588844 | ||
| Pubmed | 2.10e-06 | 18 | 182 | 4 | 20943658 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 2.10e-06 | 18 | 182 | 4 | 24367100 | |
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 2.64e-06 | 19 | 182 | 4 | 34042944 | |
| Pubmed | 2.64e-06 | 19 | 182 | 4 | 15452145 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 2.64e-06 | 19 | 182 | 4 | 14622145 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 2.64e-06 | 19 | 182 | 4 | 38048369 | |
| Pubmed | 2.64e-06 | 19 | 182 | 4 | 22841714 | ||
| Pubmed | 2.64e-06 | 19 | 182 | 4 | 23444373 | ||
| Pubmed | 2.64e-06 | 19 | 182 | 4 | 12646573 | ||
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 2.64e-06 | 19 | 182 | 4 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 2.64e-06 | 19 | 182 | 4 | 17664336 | |
| Pubmed | 2.64e-06 | 19 | 182 | 4 | 17724343 | ||
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 2.64e-06 | 19 | 182 | 4 | 34255394 | |
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 2.64e-06 | 19 | 182 | 4 | 17003038 | |
| Pubmed | 3.29e-06 | 20 | 182 | 4 | 23918928 | ||
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 3.29e-06 | 20 | 182 | 4 | 21300694 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 3.29e-06 | 20 | 182 | 4 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 3.29e-06 | 20 | 182 | 4 | 34128978 | |
| Pubmed | 3.29e-06 | 20 | 182 | 4 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 3.29e-06 | 20 | 182 | 4 | 29437892 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 3.29e-06 | 20 | 182 | 4 | 20368623 | |
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 3.29e-06 | 20 | 182 | 4 | 31949138 | |
| Pubmed | 4.05e-06 | 21 | 182 | 4 | 25708312 | ||
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 4.05e-06 | 21 | 182 | 4 | 27118846 | |
| Pubmed | 4.05e-06 | 21 | 182 | 4 | 21645620 | ||
| Pubmed | 4.05e-06 | 21 | 182 | 4 | 36292593 | ||
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 4.05e-06 | 21 | 182 | 4 | 19061864 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 4.05e-06 | 21 | 182 | 4 | 22216013 | |
| Pubmed | 4.05e-06 | 21 | 182 | 4 | 23386608 | ||
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 4.05e-06 | 21 | 182 | 4 | 20003423 | |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 23190742 | ||
| Pubmed | 4.93e-06 | 22 | 182 | 4 | 34897463 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 4.93e-06 | 22 | 182 | 4 | 36656123 | |
| Pubmed | 5.94e-06 | 23 | 182 | 4 | 25636444 | ||
| Pubmed | 5.94e-06 | 23 | 182 | 4 | 18662990 | ||
| Pubmed | 5.94e-06 | 23 | 182 | 4 | 37848288 | ||
| Pubmed | Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. | 5.94e-06 | 23 | 182 | 4 | 21111240 | |
| Pubmed | 5.94e-06 | 23 | 182 | 4 | 18001291 | ||
| Pubmed | Pofut1 is required for the proper localization of the Notch receptor during mouse development. | 5.94e-06 | 23 | 182 | 4 | 18547789 | |
| Pubmed | DHX36 ARHGEF28 ACACA PPAT BIRC6 USP19 GPR107 PTCHD1 SLC25A36 FASN TAF3 TADA1 MSMO1 PIK3CA FDFT1 CFAP20 FGF3 CLDN5 MTO1 ULK2 RAB5C | 6.88e-06 | 1327 | 182 | 21 | 32694731 | |
| Pubmed | 7.10e-06 | 24 | 182 | 4 | 26060116 | ||
| Pubmed | 7.10e-06 | 24 | 182 | 4 | 21187406 | ||
| Pubmed | 7.10e-06 | 24 | 182 | 4 | 24161848 | ||
| Pubmed | Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. | 7.10e-06 | 24 | 182 | 4 | 22364862 | |
| Pubmed | 7.10e-06 | 24 | 182 | 4 | 38814743 | ||
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 7.10e-06 | 24 | 182 | 4 | 18434600 | |
| Pubmed | The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. | 7.10e-06 | 24 | 182 | 4 | 20223754 | |
| Pubmed | Dual role for CXCL12 signaling in semilunar valve development. | 7.10e-06 | 24 | 182 | 4 | 34433040 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | VIL1 DSC2 KALRN CETP LRRK2 CDHR5 CNKSR2 SLC3A1 FASN EEF2 VPS13D FAT1 PTPRJ CFAP20 PKHD1 NID1 C5 RAB5C | 7.25e-06 | 1016 | 182 | 18 | 19056867 |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 19636338 | ||
| Pubmed | Nubp1 is required for lung branching morphogenesis and distal progenitor cell survival in mice. | 8.42e-06 | 25 | 182 | 4 | 23028652 | |
| Pubmed | 8.42e-06 | 25 | 182 | 4 | 26143639 | ||
| Pubmed | 8.42e-06 | 25 | 182 | 4 | 24161523 | ||
| Interaction | CLRN3 interactions | 3.78e-06 | 13 | 176 | 4 | int:CLRN3 | |
| GeneFamily | Cadherin related | 5.31e-06 | 17 | 128 | 4 | 24 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 9.67e-05 | 65 | 128 | 5 | 388 | |
| GeneFamily | Fibronectin type III domain containing | 1.44e-04 | 160 | 128 | 7 | 555 | |
| GeneFamily | Synapsins | 1.49e-04 | 3 | 128 | 2 | 1325 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.62e-04 | 18 | 128 | 3 | 1160 | |
| GeneFamily | Dopamine receptors | 4.90e-04 | 5 | 128 | 2 | 181 | |
| GeneFamily | Solute carriers | SLC25A46 SLC47A2 SLC3A1 SLC12A5 SLC35F5 SLCO5A1 SLC25A36 SLC16A4 SLC13A5 SLC25A29 | 5.09e-04 | 395 | 128 | 10 | 752 |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.73e-03 | 9 | 128 | 2 | 1234 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 3.69e-03 | 13 | 128 | 2 | 170 | |
| GeneFamily | Trafficking protein particle complex | 4.28e-03 | 14 | 128 | 2 | 772 | |
| Coexpression | JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN | 4.84e-06 | 65 | 175 | 6 | M18705 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 ABCA4 KALRN KIF26B CNKSR2 PKHD1L1 RYR3 FAT1 GUCY2F PCDH15 PKHD1 TENM1 ADAMTS20 SDK1 | 2.91e-14 | 184 | 179 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 ABCA4 KALRN KIF26B CNKSR2 PKHD1L1 RYR3 FAT1 GUCY2F PCDH15 PKHD1 TENM1 ADAMTS20 SDK1 | 2.91e-14 | 184 | 179 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL12A1 ABCA4 KALRN KIF26B CNKSR2 PKHD1L1 RYR3 FAT1 GUCY2F PCDH15 PKHD1 TENM1 ADAMTS20 SDK1 | 2.91e-14 | 184 | 179 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | COL6A2 SDK2 GRIA1 CNKSR2 TENM2 TMEM132C SNED1 PCDH15 NID1 SDK1 | 6.42e-09 | 193 | 179 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PKHD1L1 KIAA1549L GUCY2F ANKAR PCDH15 PKHD1 TENM1 ABCC2 TMPRSS11A | 2.04e-08 | 162 | 179 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.83e-08 | 192 | 179 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.23e-08 | 193 | 179 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.65e-08 | 194 | 179 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.65e-08 | 194 | 179 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-07 | 198 | 179 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-07 | 199 | 179 | 9 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-06 | 189 | 179 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 191 | 179 | 8 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.23e-06 | 194 | 179 | 8 | c093c5e161b97ad770bfbaad3023eba4537101b5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 194 | 179 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-06 | 196 | 179 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 198 | 179 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 198 | 179 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 199 | 179 | 8 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-06 | 199 | 179 | 8 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-06 | 199 | 179 | 8 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-06 | 199 | 179 | 8 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-06 | 200 | 179 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.54e-06 | 200 | 179 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-06 | 200 | 179 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 145 | 179 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.68e-06 | 61 | 179 | 5 | 12de8c495c7f47ecd720f29a573471705603732a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.68e-06 | 61 | 179 | 5 | a655232c6d92335eb086723ab9b05eb3a5479b68 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 5.20e-06 | 167 | 179 | 7 | 7ff186b2bed3b0de93addb3b0ae5a2c6e44ddfb2 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.31e-06 | 172 | 179 | 7 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.48e-06 | 113 | 179 | 6 | dc002185095590fc071b2f39259f8b87a757e174 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-06 | 178 | 179 | 7 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-06 | 178 | 179 | 7 | 462111b61f37338f97ac7dc6c7da1d4316b54445 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-06 | 179 | 179 | 7 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.49e-06 | 180 | 179 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.80e-06 | 181 | 179 | 7 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.12e-06 | 182 | 179 | 7 | b4f347fb684f6840c166d7473f3f56389f69c14b | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.45e-06 | 183 | 179 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.45e-06 | 183 | 179 | 7 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-06 | 183 | 179 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.80e-06 | 184 | 179 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 185 | 179 | 7 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 185 | 179 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-05 | 185 | 179 | 7 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 186 | 179 | 7 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | (4)_Lymph_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.05e-05 | 186 | 179 | 7 | 6b3afc2ae870ff73e30a60ce84fcee0eb365d809 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 186 | 179 | 7 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 187 | 179 | 7 | 8e7ac5808bb292101e33d70616ae784b951e4bf0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 189 | 179 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 189 | 179 | 7 | f0418851ad4042c4cd87c8729e4f0d43bdf8fccb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 189 | 179 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.21e-05 | 190 | 179 | 7 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.21e-05 | 190 | 179 | 7 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.25e-05 | 191 | 179 | 7 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 192 | 179 | 7 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 192 | 179 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 1.34e-05 | 193 | 179 | 7 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-05 | 193 | 179 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 194 | 179 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 194 | 179 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.43e-05 | 195 | 179 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.43e-05 | 195 | 179 | 7 | 7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.43e-05 | 195 | 179 | 7 | b61b8c931bd0ca3678486653ae1d7e9915c696c7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 195 | 179 | 7 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Healthy/Control-gd_T|World / Disease group and Cell class | 1.48e-05 | 196 | 179 | 7 | b982c84552e7efbff2be861f0f569f40804f5d88 | |
| ToppCell | Healthy/Control-gd_T|Healthy/Control / Disease group and Cell class | 1.48e-05 | 196 | 179 | 7 | a6f9e55cd1cd7facadb3f508bded68023c997f3f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 196 | 179 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.63e-05 | 199 | 179 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | tumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass | 1.63e-05 | 199 | 179 | 7 | 28ec59e01061287fb0892491790b316e2b93e232 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 200 | 179 | 7 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 200 | 179 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-05 | 200 | 179 | 7 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.95e-05 | 137 | 179 | 6 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.29e-05 | 141 | 179 | 6 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 3.01e-05 | 148 | 179 | 6 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Cartpt_(Neuron.Gad1Gad2.Pvalb-Cartpt)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-05 | 47 | 179 | 4 | ae7c9e110228e142662a671f13f0069494949791 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Cartpt_(Neuron.Gad1Gad2.Pvalb-Cartpt)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.78e-05 | 47 | 179 | 4 | e5c448273e5ceb9bb08fb10ce362a4da003d7172 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.04e-05 | 156 | 179 | 6 | fbe23876f0899853cea3c5c4f3044a9cea064d5b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-05 | 157 | 179 | 6 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 160 | 179 | 6 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.82e-05 | 161 | 179 | 6 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.82e-05 | 161 | 179 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 163 | 179 | 6 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 163 | 179 | 6 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 164 | 179 | 6 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 167 | 179 | 6 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 167 | 179 | 6 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 168 | 179 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 168 | 179 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-05 | 169 | 179 | 6 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 6.52e-05 | 170 | 179 | 6 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 173 | 179 | 6 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 7.41e-05 | 174 | 179 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.90e-05 | 176 | 179 | 6 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.90e-05 | 176 | 179 | 6 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-05 | 176 | 179 | 6 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-05 | 176 | 179 | 6 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 177 | 179 | 6 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.23e-05 | 110 | 179 | 5 | bede775886b45cce4aa229baead0e800b5be25a8 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-05 | 179 | 179 | 6 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| Drug | AC1L1CXF | 2.94e-07 | 36 | 174 | 6 | CID000002104 | |
| Drug | sarizotan | 1.75e-06 | 4 | 174 | 3 | ctd:C443959 | |
| Drug | nafadotride | 4.21e-06 | 15 | 174 | 4 | CID003408722 | |
| Drug | torcetrapib | 7.66e-06 | 36 | 174 | 5 | CID000159325 | |
| Drug | Rotigotine | 8.63e-06 | 6 | 174 | 3 | DB05271 | |
| Drug | LY293284 | 8.63e-06 | 6 | 174 | 3 | CID000132345 | |
| Drug | fluoxetine | 9.55e-06 | 225 | 174 | 10 | CID000003386 | |
| Drug | picrotoxin | 1.10e-05 | 181 | 174 | 9 | CID000031304 | |
| Drug | 7-OH-DPAT | 1.15e-05 | 39 | 174 | 5 | CID000001219 | |
| Drug | SKF 83566 | 1.45e-05 | 20 | 174 | 4 | CID000001243 | |
| Drug | FLB 457 | 1.50e-05 | 7 | 174 | 3 | CID000129497 | |
| Drug | GR218,231 | 1.50e-05 | 7 | 174 | 3 | CID005312124 | |
| Drug | anisamide | 2.16e-05 | 22 | 174 | 4 | CID000075540 | |
| Drug | 2-aminotetralin | 2.16e-05 | 22 | 174 | 4 | CID000018066 | |
| Drug | SCH-12679 | 2.39e-05 | 8 | 174 | 3 | CID000005024 | |
| Drug | bromerguride | 2.39e-05 | 8 | 174 | 3 | CID000071266 | |
| Drug | AC1L1H5B | 2.77e-05 | 77 | 174 | 6 | CID000003981 | |
| Drug | CQ 32-084 | 3.56e-05 | 9 | 174 | 3 | CID000068847 | |
| Drug | U91356A | 3.56e-05 | 9 | 174 | 3 | CID000132955 | |
| Drug | tropapride | 3.56e-05 | 9 | 174 | 3 | CID000071148 | |
| Drug | WAY-100635 | 3.57e-05 | 49 | 174 | 5 | CID000005684 | |
| Drug | Olanzapine | 3.68e-05 | 25 | 174 | 4 | DB00334 | |
| Drug | Ziprasidone | 3.68e-05 | 25 | 174 | 4 | DB00246 | |
| Drug | Aripiprazole | 3.68e-05 | 25 | 174 | 4 | DB01238 | |
| Drug | sertindole | 3.95e-05 | 50 | 174 | 5 | CID000060149 | |
| Drug | Clozapine | 4.32e-05 | 26 | 174 | 4 | DB00363 | |
| Drug | Quetiapine | 4.32e-05 | 26 | 174 | 4 | DB01224 | |
| Drug | ergolines | 5.04e-05 | 27 | 174 | 4 | CID003083577 | |
| Drug | NSC169490 | 5.04e-05 | 27 | 174 | 4 | CID004210613 | |
| Drug | Rds-127 | 5.06e-05 | 10 | 174 | 3 | CID000134064 | |
| Drug | 5-OH-DPAT | 5.06e-05 | 10 | 174 | 3 | CID000172267 | |
| Drug | Yohimbine | 5.06e-05 | 10 | 174 | 3 | DB01392 | |
| Drug | 2-(di-n-propylamino)tetralin | 5.06e-05 | 10 | 174 | 3 | CID000090285 | |
| Drug | S 14297 | 5.06e-05 | 10 | 174 | 3 | CID000115007 | |
| Drug | U-86170F | 5.06e-05 | 10 | 174 | 3 | CID000131559 | |
| Drug | SDZ 208-912 | 5.06e-05 | 10 | 174 | 3 | CID000058145 | |
| Drug | Piperazinehexanamide derivative, 12 | 5.81e-05 | 2 | 174 | 2 | CID011385991 | |
| Drug | Piperazinehexanamide derivative, 10 | 5.81e-05 | 2 | 174 | 2 | CID011431529 | |
| Drug | Buspirone | 5.81e-05 | 2 | 174 | 2 | DB00490 | |
| Drug | SureCN4460956 | 5.81e-05 | 2 | 174 | 2 | CID011191127 | |
| Drug | Sulpiride | 5.81e-05 | 2 | 174 | 2 | DB00391 | |
| Drug | N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride | 5.81e-05 | 2 | 174 | 2 | ctd:C016868 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 5.81e-05 | 2 | 174 | 2 | ctd:C051171 | |
| Drug | CGS 15855A | 5.81e-05 | 2 | 174 | 2 | ctd:C051347 | |
| Drug | Piperazinehexanamide derivative, 13 | 5.81e-05 | 2 | 174 | 2 | CID011248331 | |
| Drug | (5,6-dimethoxyindan-2-yl)dipropylamine | 5.81e-05 | 2 | 174 | 2 | ctd:C086335 | |
| Drug | Domperidone | 5.81e-05 | 2 | 174 | 2 | DB01184 | |
| Drug | Lp44 | 5.81e-05 | 2 | 174 | 2 | CID011224758 | |
| Drug | 1,4-benzoxazepine | 5.81e-05 | 2 | 174 | 2 | CID014712340 | |
| Drug | UH 232 | 5.81e-05 | 2 | 174 | 2 | ctd:C045971 | |
| Drug | N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate | 5.81e-05 | 2 | 174 | 2 | ctd:C561226 | |
| Drug | 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline | 5.81e-05 | 2 | 174 | 2 | ctd:C416545 | |
| Drug | SureCN4462276 | 5.81e-05 | 2 | 174 | 2 | CID011282296 | |
| Drug | Piperazinehexanamide derivative, 11 | 5.81e-05 | 2 | 174 | 2 | CID011329253 | |
| Drug | 3-(3-cyanophenyl)-N-n-propylpiperidine | 5.81e-05 | 2 | 174 | 2 | ctd:C094012 | |
| Drug | iodosulpride | 5.81e-05 | 2 | 174 | 2 | ctd:C045105 | |
| Drug | fluoroclebopride | 5.81e-05 | 2 | 174 | 2 | ctd:C083673 | |
| Drug | Uc39 | 5.81e-05 | 2 | 174 | 2 | CID003000889 | |
| Drug | (3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl)methyl)-8-azabicyclo(3.2.1)octane-3-methanamine monohydrochloride | 5.81e-05 | 2 | 174 | 2 | ctd:C480819 | |
| Drug | SureCN4464192 | 5.81e-05 | 2 | 174 | 2 | CID011785182 | |
| Drug | pardoprunox | 5.81e-05 | 2 | 174 | 2 | ctd:C480679 | |
| Drug | N-(4-(4-(3-aminocarbonyl-phenyl)-piperazin-1-yl)-butyl)-4-bromo-benzamide | 5.81e-05 | 2 | 174 | 2 | ctd:C518644 | |
| Drug | GR 218231 | 5.81e-05 | 2 | 174 | 2 | ctd:C408390 | |
| Drug | N-(4-(2-(4-(3-cyano-5-trifluoromethylphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-pyridinesulfonic amide | 5.81e-05 | 2 | 174 | 2 | ctd:C539157 | |
| Drug | Piribedil | 5.81e-05 | 2 | 174 | 2 | ctd:D010891 | |
| Drug | AC1L31N6 | 5.81e-05 | 2 | 174 | 2 | CID000132830 | |
| Drug | SureCN4458829 | 5.81e-05 | 2 | 174 | 2 | CID011432176 | |
| Drug | NSC407316 | 5.85e-05 | 28 | 174 | 4 | CID000003067 | |
| Drug | muscimol | 6.16e-05 | 129 | 174 | 7 | CID000004266 | |
| Drug | Phenobarbital | 6.92e-05 | 11 | 174 | 3 | DB01174 | |
| Drug | NNC 112 | 6.92e-05 | 11 | 174 | 3 | CID000130424 | |
| Drug | 6-Br-APB | 6.92e-05 | 11 | 174 | 3 | CID000005016 | |
| Drug | carboxyphosphate | 6.92e-05 | 11 | 174 | 3 | CID000195869 | |
| Drug | quetiapine | 7.47e-05 | 57 | 174 | 5 | CID000005002 | |
| Drug | 2-naphthalenesulfonate | 7.57e-05 | 92 | 174 | 6 | CID000008420 | |
| Drug | AC1L1G8Z | 7.73e-05 | 30 | 174 | 4 | CID000003581 | |
| Drug | mesulergine | 8.82e-05 | 31 | 174 | 4 | CID000068848 | |
| Drug | xanomeline | 8.82e-05 | 31 | 174 | 4 | CID000060809 | |
| Drug | paliperidone | 8.82e-05 | 31 | 174 | 4 | CID000115237 | |
| Drug | tetrahydronaphthalen-1-ol | 9.17e-05 | 12 | 174 | 3 | CID000001240 | |
| Drug | ocaperidone | 9.17e-05 | 12 | 174 | 3 | CID000071351 | |
| Drug | 1,3-di-o-tolylguanidine | 1.04e-04 | 61 | 174 | 5 | CID000007333 | |
| Drug | bifeprunox | 1.19e-04 | 13 | 174 | 3 | CID000208951 | |
| Drug | Spiperone | 1.19e-04 | 13 | 174 | 3 | ctd:D013134 | |
| Drug | cycloartenol | 1.19e-04 | 13 | 174 | 3 | CID000092110 | |
| Drug | AP-7 | 1.21e-04 | 63 | 174 | 5 | CID000003122 | |
| Drug | CGS 12066B | 1.28e-04 | 34 | 174 | 4 | CID000002689 | |
| Drug | fluspirilene | 1.28e-04 | 34 | 174 | 4 | CID000003396 | |
| Drug | 7 cholesterol | 1.30e-04 | 64 | 174 | 5 | CID000000420 | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 174 | 8 | 4412_DN | |
| Drug | 5,7-dihydroxytryptamine | 1.40e-04 | 65 | 174 | 5 | CID000035781 | |
| Drug | Lisuride | 1.50e-04 | 14 | 174 | 3 | DB00589 | |
| Drug | Pramipexole | 1.50e-04 | 14 | 174 | 3 | DB00413 | |
| Drug | Ropinirole | 1.50e-04 | 14 | 174 | 3 | DB00268 | |
| Drug | Risperidone | 1.50e-04 | 14 | 174 | 3 | DB00734 | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.52e-04 | 199 | 174 | 8 | 5997_UP | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.57e-04 | 200 | 174 | 8 | 3167_UP | |
| Drug | 4-AP | 1.73e-04 | 258 | 174 | 9 | CID000001727 | |
| Drug | (1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate) | 1.73e-04 | 3 | 174 | 2 | ctd:C461261 | |
| Drug | DP-6OH-3CA | 1.73e-04 | 3 | 174 | 2 | CID000086146 | |
| Disease | Generalized seizures | 2.20e-06 | 101 | 172 | 7 | C0234533 | |
| Disease | Clonic Seizures | 2.20e-06 | 101 | 172 | 7 | C0234535 | |
| Disease | Convulsive Seizures | 2.20e-06 | 101 | 172 | 7 | C0751494 | |
| Disease | Seizures, Sensory | 2.20e-06 | 101 | 172 | 7 | C0751496 | |
| Disease | Non-epileptic convulsion | 2.20e-06 | 101 | 172 | 7 | C0751056 | |
| Disease | Atonic Absence Seizures | 2.20e-06 | 101 | 172 | 7 | C0751123 | |
| Disease | Complex partial seizures | 2.20e-06 | 101 | 172 | 7 | C0149958 | |
| Disease | Single Seizure | 2.20e-06 | 101 | 172 | 7 | C0751110 | |
| Disease | Nonepileptic Seizures | 2.20e-06 | 101 | 172 | 7 | C3495874 | |
| Disease | Visual seizure | 2.20e-06 | 101 | 172 | 7 | C0270824 | |
| Disease | Epileptic drop attack | 2.20e-06 | 101 | 172 | 7 | C0270846 | |
| Disease | Vertiginous seizure | 2.20e-06 | 101 | 172 | 7 | C0422855 | |
| Disease | Gustatory seizure | 2.20e-06 | 101 | 172 | 7 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.20e-06 | 101 | 172 | 7 | C0422850 | |
| Disease | Olfactory seizure | 2.20e-06 | 101 | 172 | 7 | C0422853 | |
| Disease | Seizures, Auditory | 2.20e-06 | 101 | 172 | 7 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.20e-06 | 101 | 172 | 7 | C4505436 | |
| Disease | Jacksonian Seizure | 2.20e-06 | 101 | 172 | 7 | C0022333 | |
| Disease | Epileptic Seizures | 2.20e-06 | 101 | 172 | 7 | C4317109 | |
| Disease | Absence Seizures | 2.35e-06 | 102 | 172 | 7 | C4316903 | |
| Disease | Convulsions | 2.35e-06 | 102 | 172 | 7 | C4048158 | |
| Disease | Tonic Seizures | 2.35e-06 | 102 | 172 | 7 | C0270844 | |
| Disease | Seizures, Focal | 2.67e-06 | 104 | 172 | 7 | C0751495 | |
| Disease | Myoclonic Seizures | 2.67e-06 | 104 | 172 | 7 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.67e-06 | 104 | 172 | 7 | C0494475 | |
| Disease | Cocaine-Related Disorders | 5.86e-06 | 117 | 172 | 7 | C0236736 | |
| Disease | Cocaine Abuse | 1.00e-05 | 127 | 172 | 7 | C0009171 | |
| Disease | Cocaine Dependence | 1.81e-05 | 139 | 172 | 7 | C0600427 | |
| Disease | Usher syndrome, type 1D | 3.38e-05 | 2 | 172 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 3.38e-05 | 2 | 172 | 2 | C1832845 | |
| Disease | USHER SYNDROME, TYPE ID | 3.38e-05 | 2 | 172 | 2 | 601067 | |
| Disease | Usher syndrome type 1D | 3.38e-05 | 2 | 172 | 2 | cv:C1832845 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 3.38e-05 | 2 | 172 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | retinal degeneration (implicated_via_orthology) | 4.00e-05 | 33 | 172 | 4 | DOID:8466 (implicated_via_orthology) | |
| Disease | Seizures | 4.46e-05 | 218 | 172 | 8 | C0036572 | |
| Disease | Malignant neoplasm of breast | ERCC3 ABCA4 KALRN TRAPPC8 MAP3K6 SLAMF1 PHKB FASN EEF2 PIK3CA GUCY2F TENM1 MROH7 FGF3 CDC27 CPSF3 VPS13B GABRA4 | 6.02e-05 | 1074 | 172 | 18 | C0006142 |
| Disease | Colorectal Carcinoma | ABCA4 ACACA KALRN CNKSR2 SLC12A5 CNPPD1 FAT1 PIK3CA PKHD1 TENM1 NID1 ABCC2 PZP RAB5C | 6.84e-05 | 702 | 172 | 14 | C0009402 |
| Disease | Disruptive, Impulse Control, and Conduct Disorders | 1.01e-04 | 3 | 172 | 2 | C0021122 | |
| Disease | Intermittent Explosive Disorder | 1.01e-04 | 3 | 172 | 2 | C0021776 | |
| Disease | Cannabis Dependence | 1.25e-04 | 17 | 172 | 3 | C0006870 | |
| Disease | Ullrich congenital muscular dystrophy | 2.01e-04 | 4 | 172 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 2.01e-04 | 4 | 172 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 2.01e-04 | 4 | 172 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 2.01e-04 | 4 | 172 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 2.01e-04 | 4 | 172 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 2.01e-04 | 4 | 172 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Schizophrenia | DRD2 DRD3 HTR1A GPR50 GRIA1 SLC12A5 CNPPD1 IGF2BP2 PIK3CA ERVK-8 SYN1 SYN2 CLDN5 IL2RA GABRA4 | 2.19e-04 | 883 | 172 | 15 | C0036341 |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 2.25e-04 | 51 | 172 | 4 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | Usher syndrome, type 1A | 3.34e-04 | 5 | 172 | 2 | C2931205 | |
| Disease | heroin dependence (biomarker_via_orthology) | 3.34e-04 | 5 | 172 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 3.34e-04 | 5 | 172 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 3.34e-04 | 5 | 172 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 3.34e-04 | 5 | 172 | 2 | C1848640 | |
| Disease | muscular disease (implicated_via_orthology) | 3.34e-04 | 5 | 172 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Usher syndrome type 1 | 3.34e-04 | 5 | 172 | 2 | cv:C1568247 | |
| Disease | epilepsy (implicated_via_orthology) | 4.01e-04 | 163 | 172 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | free cholesterol in very large HDL measurement | 4.78e-04 | 62 | 172 | 4 | EFO_0022273 | |
| Disease | Usher Syndrome, Type I | 4.99e-04 | 6 | 172 | 2 | C1568247 | |
| Disease | anxiety disorder (is_implicated_in) | 4.99e-04 | 6 | 172 | 2 | DOID:2030 (is_implicated_in) | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 5.14e-04 | 27 | 172 | 3 | C1112155 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 6.20e-04 | 321 | 172 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 6.36e-04 | 29 | 172 | 3 | C1333990 | |
| Disease | Alcohol abuse | 6.42e-04 | 67 | 172 | 4 | C0085762 | |
| Disease | Hereditary retinal dystrophy | 6.96e-04 | 7 | 172 | 2 | C0154860 | |
| Disease | Usher syndrome | 6.96e-04 | 7 | 172 | 2 | cv:C0271097 | |
| Disease | D dimer measurement | 7.04e-04 | 30 | 172 | 3 | EFO_0004507 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 7.42e-04 | 330 | 172 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 7.99e-04 | 71 | 172 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Hyperkinesia | 8.53e-04 | 32 | 172 | 3 | C3887506 | |
| Disease | Mental Retardation, X-Linked 1 | 8.53e-04 | 32 | 172 | 3 | C2931498 | |
| Disease | Hyperkinesia, Generalized | 8.53e-04 | 32 | 172 | 3 | C0751217 | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 9.24e-04 | 8 | 172 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | depressive symptom measurement | 9.30e-04 | 426 | 172 | 9 | EFO_0007006 | |
| Disease | ovarian neoplasm | 1.16e-03 | 134 | 172 | 5 | C0919267 | |
| Disease | Tremor, Neonatal | 1.18e-03 | 9 | 172 | 2 | C0235843 | |
| Disease | Tremor, Perioral | 1.18e-03 | 9 | 172 | 2 | C0235078 | |
| Disease | Nerve Tremors | 1.18e-03 | 9 | 172 | 2 | C0235083 | |
| Disease | Tremor, Limb | 1.18e-03 | 9 | 172 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 1.18e-03 | 9 | 172 | 2 | C0235082 | |
| Disease | Senile Tremor | 1.18e-03 | 9 | 172 | 2 | C0149840 | |
| Disease | Heroin Dependence | 1.18e-03 | 9 | 172 | 2 | C0019337 | |
| Disease | Heroin Smoking | 1.18e-03 | 9 | 172 | 2 | C4505390 | |
| Disease | Pill Rolling Tremor | 1.18e-03 | 9 | 172 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 1.18e-03 | 9 | 172 | 2 | C0751565 | |
| Disease | Recurrent depression | 1.18e-03 | 9 | 172 | 2 | C0221480 | |
| Disease | Action Tremor | 1.18e-03 | 9 | 172 | 2 | C0234376 | |
| Disease | Passive Tremor | 1.18e-03 | 9 | 172 | 2 | C0234377 | |
| Disease | Static Tremor | 1.18e-03 | 9 | 172 | 2 | C0234378 | |
| Disease | Resting Tremor | 1.18e-03 | 9 | 172 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 1.18e-03 | 9 | 172 | 2 | C0234372 | |
| Disease | Fine Tremor | 1.18e-03 | 9 | 172 | 2 | C0234373 | |
| Disease | Coarse Tremor | 1.18e-03 | 9 | 172 | 2 | C0234374 | |
| Disease | Massive Tremor | 1.18e-03 | 9 | 172 | 2 | C0234375 | |
| Disease | Persistent Tremor | 1.18e-03 | 9 | 172 | 2 | C0234370 | |
| Disease | Continuous Tremor | 1.18e-03 | 9 | 172 | 2 | C0234371 | |
| Disease | Darkness Tremor | 1.18e-03 | 9 | 172 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 1.18e-03 | 9 | 172 | 2 | C1527384 | |
| Disease | heroin abuse | 1.18e-03 | 9 | 172 | 2 | C0600241 | |
| Disease | Major depression, single episode | 1.18e-03 | 9 | 172 | 2 | C0024517 | |
| Disease | Saturnine Tremor | 1.18e-03 | 9 | 172 | 2 | C0040827 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYDAIVTESGEVIST | 131 | P0DKL9 | |
| GNTIDTYTTVETLLN | 841 | Q8NHU2 | |
| VAYTFEEDIVTTVQA | 376 | P11597 | |
| YTNTEFVIVVVDSTD | 81 | Q9Y689 | |
| YSNTEFIILVVDSID | 81 | Q96KC2 | |
| IQKTAEIVYAATTSL | 4481 | Q9NR09 | |
| YADTVTTVILEVQSN | 576 | Q9UKF6 | |
| IEEYSVTQTTLDQVF | 2231 | P78363 | |
| IQTLVEISQDGTSYS | 666 | O14514 | |
| VVVYDQSTRDASVLA | 86 | Q13202 | |
| ELIVGLSIYTVSSEV | 311 | P28566 | |
| LISYVISSSVANLTV | 531 | Q8IZP9 | |
| ESSLAYNEIITISLV | 1806 | Q13085 | |
| ETITIEELGTLVTYQ | 516 | Q8TF62 | |
| VESTVNSVICTRTYE | 116 | A6NFH5 | |
| DLARYSVTQVTVEAV | 331 | Q9HBB8 | |
| VATYEVTLSVIDNAS | 2251 | Q9H251 | |
| TRTSYVTSVEENTVD | 356 | Q02487 | |
| YEDAVSIATAVLVVV | 131 | O75185 | |
| QAIQATAETVYDILS | 1806 | Q2TAZ0 | |
| EIYVISAETFTALSV | 91 | P24539 | |
| VNEIVYNSSTISLTS | 1566 | P59510 | |
| ERSAIYVATVETLAQ | 141 | Q709F0 | |
| ESTLSALQYVSSIVV | 296 | Q04656 | |
| TTLVTATVENETYTL | 281 | Q14627 | |
| SDLSVTITQASYVTL | 286 | Q68CQ1 | |
| EAELSVSSVYNLLTV | 606 | P20742 | |
| IRDSTIAVVVYDITN | 101 | Q5JT25 | |
| AAIVVYDITNTDTFA | 96 | P51148 | |
| STVAVVVYDITNVNS | 86 | P20340 | |
| STVAVVVYDITNLNS | 86 | Q9NRW1 | |
| SAAAVVVYDITNVNS | 86 | Q9H0N0 | |
| SAAAVVVYDITNVNS | 86 | Q53S08 | |
| YQELAVALESSSVTI | 71 | Q9NYA3 | |
| NVAYIIIESTEEGTT | 381 | Q5VW38 | |
| VVSVAEITFDTSVYS | 1066 | P20702 | |
| ALVTYSLTDDTVQGV | 486 | Q9Y5H2 | |
| EVTTLTVKYQVSEEV | 26 | Q9NPG4 | |
| EIVYSLGSDVSSTIQ | 276 | Q9Y5H9 | |
| LDISYINIEGITATT | 386 | Q8N1W1 | |
| TILVDSLYSVQTSTI | 1216 | Q7Z5J8 | |
| SINLSTIVDVYTVEQ | 291 | Q8N635 | |
| SVSIFSSASLAVEYV | 6 | Q15800 | |
| VSEYNITVTATDQGT | 446 | Q9Y5G9 | |
| SLTQAQVASVFYTIV | 266 | Q8N0Y5 | |
| SLSSTCYVEVEVVDV | 1011 | Q14517 | |
| VYESAAVGSVVLQVT | 1571 | Q14517 | |
| QSYAVTLSEASVIGT | 2286 | Q14517 | |
| ESAEITITTQTGYSL | 9656 | Q8WXI7 | |
| TVYTALDIATGQEVA | 296 | O75914 | |
| SAVFDIHVVYVTTTE | 541 | Q12913 | |
| EEANIYAVKTAVSVT | 311 | P40425 | |
| VLSTIEQYAALATGT | 141 | P51787 | |
| VEQVVTSAAEAYQVL | 201 | Q9NS87 | |
| VLTQTEEILSANATY | 131 | Q8IU57 | |
| SVVYNASTKVVTITD | 876 | Q2M2H8 | |
| VVLIAETDSQYTSAV | 181 | Q9UQ53 | |
| YSILETVATLDQQVV | 1176 | Q6ZRQ5 | |
| VVLVDGSTVYAESVI | 176 | Q9Y2Z2 | |
| VLEIEGTNVSTTYIT | 46 | Q9Y6A4 | |
| AVGSYAETLSTIQIA | 781 | Q2KJY2 | |
| SAYSILEITAVEVGI | 71 | P11487 | |
| TITTVDSCVVQLDYL | 171 | Q9UPZ3 | |
| TVVTTSTNDYHDVVV | 591 | Q13585 | |
| LTTLSQVTEDYVQTG | 401 | P37268 | |
| LGDSITEVFTNIYVT | 61 | P47869 | |
| YNADVVVLEVSSSLV | 111 | O95382 | |
| IAEYSLIVNTATETA | 186 | Q63HM2 | |
| LTSVAVASVNNYTAV | 471 | Q9Y4D7 | |
| YSILTEQESQASAVT | 386 | Q8IXI2 | |
| SVTTYKIEDSFVIAV | 216 | P55157 | |
| IDAVYVTTNGIIATS | 71 | P14543 | |
| QQSVASTLDTYLVIE | 2616 | O60229 | |
| VEVTELTDVTYTSNL | 601 | Q9Y2G8 | |
| TVDGSSVTVEIYDVN | 491 | Q8IY47 | |
| SVYTITSNDISVNTV | 386 | Q99550 | |
| QTVQAVRCVTSYTVE | 871 | Q9P1Y6 | |
| DVLVYVTSNDTTVLL | 281 | Q86VI4 | |
| YAAFSDSNIITVVVD | 2346 | Q5S007 | |
| DSNIITVVVDTALYI | 2351 | Q5S007 | |
| YDTIQLTITFEESVV | 2151 | Q8NG31 | |
| LVQYDLIGQTVSSET | 221 | P48169 | |
| LVSVVTFSVYVLVDS | 556 | Q92887 | |
| STSNASQAVTLVYVV | 991 | Q6ZVL6 | |
| TDTETAVVNVTYATR | 116 | Q9Y6M1 | |
| SNVTFYLVLSTTEVT | 786 | P23229 | |
| LTESVVLTVSLNYGE | 36 | Q6IE36 | |
| TITATVILVSAGEAY | 61 | O43688 | |
| YQELAVALESSSVTI | 71 | A6NDN3 | |
| LLQDESSYIFVSVTQ | 61 | P42336 | |
| SASDKDQLVAVTYTV | 266 | Q8NGX3 | |
| DITVYETTVYISSIL | 191 | Q8NHA4 | |
| TRYSDTTAEILVTVI | 996 | A2PYH4 | |
| VVSVAEITFDTSVYS | 1061 | Q13349 | |
| SPVFTNSTYTVLVEE | 816 | Q96QU1 | |
| TSYVLRVQADSLEVV | 1101 | Q96QU1 | |
| AVAYVSSVALAVASV | 236 | Q9BV87 | |
| VAQSIIIIFAAYDTT | 296 | Q9HB55 | |
| SQTLYTVSVSAVHDE | 1626 | Q99715 | |
| TNIAETSITIDDVVY | 551 | Q9H2U1 | |
| IESLEVEVSYVACTT | 306 | A4D1U4 | |
| ISTESIQTYEETAVI | 631 | Q12934 | |
| YKVSITSITVENVFV | 1561 | P01031 | |
| VLTITVESQEKTFYQ | 311 | P51841 | |
| VVFVIDSSESIGYTN | 616 | P12110 | |
| YQELAVALESSSVTI | 71 | A6NDK9 | |
| TGISDVTVSYQVITS | 26 | P08908 | |
| VNAATFATVTVVLTY | 261 | Q8N8R3 | |
| ETSIFTTEYQVAVAG | 231 | P01589 | |
| VSVDVSPVVSTYDSE | 341 | Q8IWC1 | |
| YQELAVALESSSVTI | 71 | P0CG33 | |
| TTTYAVTSILRVAAE | 276 | P01877 | |
| VVSYRETVSEESNVL | 576 | P13639 | |
| QTTTNYLIVSLAVAD | 66 | P14416 | |
| AVSVGLQTSDITEYL | 126 | P19447 | |
| IVSSELNQDSVYSSV | 451 | Q8NDH2 | |
| VEDQSITYTNIITFS | 331 | Q86UP6 | |
| QVTAVNILTTTEEGY | 171 | P42261 | |
| TLEEAASVPVVYSTA | 1641 | P49327 | |
| VVESTGVYLSIQAAS | 166 | O14556 | |
| TKYVSDATVAIFVAT | 351 | Q86YT5 | |
| SSLTTYTIDVAAVTA | 1036 | Q7Z5N4 | |
| AGEVQTSTYLAVTSI | 386 | Q58EX2 | |
| VLVSTVTEVEQYQSK | 811 | Q68D06 | |
| LNTDSSVSYIDSAVI | 226 | P30260 | |
| SVSYIDSAVISPDTV | 231 | P30260 | |
| LSSGETYVLQVSVAS | 1161 | Q8TDX9 | |
| AETSITINDVVYVID | 716 | Q08211 | |
| QTTTNYLVVSLAVAD | 61 | P35462 | |
| ISSGLQIIYNTDEVS | 186 | Q93100 | |
| QVTLLDTVELATYTV | 1476 | P10586 | |
| SISYTLSRAQTVVVE | 76 | Q96FA3 | |
| AIATTSAVYISSVVL | 461 | Q9H2X9 | |
| EVILYDITAESVSVL | 71 | Q3ZCT8 | |
| SVVTETVSTYVIRDE | 846 | Q5VWG9 | |
| IASVVALTKTYATAE | 291 | P17600 | |
| IASVVALTQTYATAE | 291 | Q92777 | |
| SVLVSQAVTSEAYVS | 281 | Q8NBJ9 | |
| EIVSAVNSVSVYRLD | 871 | Q07890 | |
| LSYQEALSDTQVAIV | 256 | Q8WV83 | |
| VVDLSAQAVIYEVAT | 321 | Q86VL8 | |
| VVTAYVTISSNSSVD | 306 | Q8N3T6 | |
| NVTEEAVSAVVYAVE | 166 | Q96BN2 | |
| LSEYLTVVIFTASAQ | 536 | P09917 | |
| VQSQSSASSEDYIII | 721 | Q14596 | |
| IVATATQTIEYTTAQ | 531 | Q96NR3 | |
| IYEDSIVLQSVFTSV | 1546 | P51532 | |
| ESVQETNSITVYASV | 316 | Q13291 | |
| FVSLSYTAESAIVTA | 436 | Q9H2Y9 | |
| LDTVSGNSVYEVITS | 416 | Q07837 | |
| SSSVTLYISEVQLNT | 36 | Q96CQ1 | |
| VLYDTTQVTLTYEES | 1981 | Q9UKZ4 | |
| VITNLSSVEASYTVV | 1746 | Q9NT68 | |
| SSVEASYTVVQDQVR | 1751 | Q9NT68 | |
| ETVEISEVQLVYNSS | 436 | Q8N3P4 | |
| YVDEIIIADTNVTVS | 701 | P08F94 | |
| ALYTVIETVADQTVA | 46 | Q6NUK4 | |
| VTEELIVVTSYTLGQ | 366 | Q9UEE5 | |
| SLLEAYVINVTTSQS | 1131 | Q8TER0 | |
| VEYIVSTNTVVLANV | 431 | O00327 | |
| VYDSVLALSTEVQAA | 66 | O00501 | |
| SLIYQVQVVGTSSEV | 436 | Q9H2X0 | |
| ELTTIVQQDCTVYET | 166 | Q8WXI2 | |
| SAYVVQATRDVETAL | 516 | P63136 | |
| ITAEEAVAVYTTTVH | 801 | Q6P2Q9 | |
| VVSRIDAYEVVESSS | 541 | O94827 | |
| ASQDEITASAYQAVI | 451 | P09327 | |
| STVTTVDESQVVTRY | 1191 | O94966 | |
| ASYLVSVAGILETVS | 336 | O15374 | |
| FYSASLIETVQSEII | 216 | Q96AG3 | |
| DEDTTVTIPSAVYVA | 126 | Q8NBT2 | |
| YTTSDAVISTETVFI | 36 | P51571 | |
| TTTVNVIISTVDYLL | 3761 | Q15413 | |
| VTVTVLSTKQTEDYC | 236 | O43278 | |
| SVVYLSVEGLVSSVQ | 456 | Q06203 | |
| SDSAYVVQATRVVET | 516 | P63133 | |
| TDSSEVYVSQVTQKV | 321 | O75830 | |
| EIVITTTSYDFHQTE | 3196 | Q86WI1 | |
| YSEALEVVNQITVTS | 196 | Q8NDW8 | |
| LYTLGIESVVTASVA | 131 | O75865 | |
| SAVSLYQIQESVVVD | 856 | Q8IYT8 | |
| DIVLSVNITSAECYT | 166 | Q7Z7G8 | |
| VITAGDYDLNISATT | 106 | Q9Y2L5 | |
| SAYVVQATRDVETAL | 521 | Q9WJR5 | |
| KDYITIQSIAASSIV | 116 | Q5HYJ1 | |
| IQSIAASSIVTLYAT | 121 | Q5HYJ1 | |
| SAAREYDIAVVQVSS | 266 | Q6ZMR5 | |
| YDIAVVQVSSRVTFS | 271 | Q6ZMR5 | |
| DINITSVLIDQYVST | 2801 | Q5THJ4 | |
| AADLEVISYSSKVSV | 26 | Q86SY8 | |
| IGTSIFTVYEAASQE | 266 | Q8IZF0 |